Key Data Files for this Active Pharmaceutical Ingredient:

Drug Master Files, 21 CFR, and other industry portals Patent/Exclusivity data file Drug Approval Drug Safety Freedom of Information Federal Register pages Pharma Companies Pharmacopeial Information Preferred API Supplier (Clients Only)

FDA Approval Activities for this Drug… Xalatan (latanoprost) ophthalmic solution, 0.005%, Pharmacia & Upjohn Company NDA 20-597/S28 & S29 7/14/03 7/28/03 Xalatan (latanoprost) ophthalmic solution, 0.005%, Pharmacia & Upjohn Company NDA 20-597/S-025 8/26/02 8/30/02 8/26/02 Xalatan (latanoprost) ophthalmic solution, 0.005%, Pharmacia & Upjohn Company NDA 20-597/S-023 11/26/01 4/28/03 Xalatan (latanoprost) ophthalmic solution, 0.005%, Pharmacia & Upjohn Company NDA 20-597/S-019 8/8/01 4/28/03 Xalatan (latanoprost) ophthalmic solution, 0.005%, Pharmacia & Upjohn Company NDA 20-597/S-010   For the latest approval information, locate this drug using this index.